Vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma

BMJ Case Rep. 2024 May 21;17(5):e256818. doi: 10.1136/bcr-2023-256818.

Abstract

Vanishing bile duct syndrome is an uncommon condition characterised by the progressive loss and disappearance of bile ducts. It is an acquired form of cholestatic liver disease presenting with hepatic ductopenia (loss of >50% bile ducts in the portal areas). We present a case of vanishing bile duct syndrome as a presentation of Hodgkin's lymphoma who was treated with standard-of-care chemotherapy-doxorubicin, bleomycin, vinblastine and dacarbazine (along with brief administration of rituximab), which led to complete response and normalisation of liver function.

Keywords: Drugs and medicines; Medical management; Oncology.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Bile Duct Diseases / diagnosis
  • Bleomycin* / administration & dosage
  • Bleomycin* / therapeutic use
  • Dacarbazine / administration & dosage
  • Dacarbazine / therapeutic use
  • Doxorubicin / therapeutic use
  • Female
  • Hodgkin Disease* / complications
  • Hodgkin Disease* / diagnosis
  • Hodgkin Disease* / drug therapy
  • Humans
  • Rituximab / administration & dosage
  • Rituximab / therapeutic use
  • Syndrome
  • Vinblastine / administration & dosage
  • Vinblastine / therapeutic use

Substances

  • Bleomycin
  • Dacarbazine
  • Doxorubicin
  • Rituximab
  • Vinblastine